ROSARIO MARÍA SÁNCHEZ MARTÍN-rekin lankidetzan egindako argitalpenak (10)

2013

  1. Antiproliferative activity, cell cycle, and apoptosis studies of a series of 6-substituted 9H-purin-9-yl-pyridinium derivatives on a human cervical carcinoma cell line

    ChemMedChem, Vol. 8, Núm. 8, pp. 1266-1269

2007

  1. QSAR as a tool for the development of potent antiproliferative agents by inhibition of choline kinase

    Current Computer-Aided Drug Design, Vol. 3, Núm. 4, pp. 297-313

2006

  1. (Q)SAR studies to design new human choline kinase inhibitors as antiproliferative drugs

    Current Medicinal Chemistry, Vol. 13, Núm. 11, pp. 1231-1248

2005

  1. 1H and 13C spectral assignment of symmetrical bis[(4-aminosubstituted)quinolinium] derivatives

    Magnetic Resonance in Chemistry, Vol. 43, Núm. 12, pp. 1066-1071

  2. Symmetrical bis-quinolinium compounds: New human choline kinase inhibitors with antiproliferative activity against the HT-29 cell line

    Journal of Medicinal Chemistry, Vol. 48, Núm. 9, pp. 3354-3363

  3. Towards a model for the inhibition of choline kinase by a new type of inhibitor

    European Journal of Medicinal Chemistry, Vol. 40, Núm. 3, pp. 315-319

2004

  1. Influence of the linker in bispyridium compounds on the inhibition of human choline kinase

    Journal of Medicinal Chemistry, Vol. 47, Núm. 22, pp. 5433-5440

2003

  1. Bispyridinium cyclophanes: Novel templates for human choline kinase inhibitors

    Journal of Medicinal Chemistry, Vol. 46, Núm. 17, pp. 3754-3757

  2. Conformational Dynamics of a Bispyridinium Cyclophane

    Journal of Organic Chemistry, Vol. 68, Núm. 22, pp. 8697-8699

  3. QSAR-derived Choline Kinase inhibitors: How rational can antiproliferative drug design be?

    Current Medicinal Chemistry, Vol. 10, Núm. 13, pp. 1095-1112